Abstract
The cover presents the active pharmaceutical ingredient paclitaxel (PTX) loaded in nanorocket propelling to malignant proliferative cells. It illustrates a “three-vector” design for nanomedicine development, a drug payload on a nanocarrier, accompanied by functional molecules to implement targeted delivery and stimulus-responsive release. This is reported by Xin-Ming Xu, Hui Xu, Tao Zhang, and co-workers in article number 2200281
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
